Integrative Analysis of Non-coding RNAs and Hippo Signaling Pathway in Hepatocellular Carcinoma Using Bioinformatics and Experimental Approaches
International Journal of Cancer Management · 11.01.2025 · 18 (1)
DOI: 10.5812/ijcm-157228 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer Management, online erschienen am 11.01.2025. Verfasst von Farzin Mirzaei-Nasab und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal malignancies globally. Non-coding RNAs (ncRNAs) are pivotal in regulating gene expression and cancer progression, yet their precise functions within HCC pathways remain elucidated.
Objectives
To investigate the role of ncRNAs in regulating key genes involved in Hippo signaling and HCC pathways and to identify potential novel regulatory mechanisms in HCC progression.
Methods
Gene expression data from the GEO database (GSE14520) were analyzed for expression changes of LEF1, MOB1A, PRKCB, and SMARCA2 in HCC. Physical interactions between selected ncRNAs (lnc-LRR1-1:1, lnc-LRR1-1:2, and hsa_circ_0001380) and target mRNAs were predicted, using the long non-coding RNA-target analysis resource (LncTAR) tool. miRNA analysis was performed to identify potential competing endogenous RNA (ceRNA) mechanisms. qPCR analysis in HCC cell lines was conducted for experimental validation.
Results
Significant upregulation of LEF1 and downregulation of PRKCB were observed in HCC samples. The strongest predicted interactions were identified between lnc-LRR1-1:2 and MOB1A isoforms. miRNA analysis suggested that the studied ncRNAs could act as ceRNAs. qPCR analysis confirmed upregulation of hsa_circ_0001380 and slight downregulation of lnc-LRR1-1:1,2 in HCC cell lines.
Conclusions
This study unveils a complex regulatory network, where ncRNAs can modulate the expression of key genes in HCC. The predicted interactions, particularly between lnc-LRR1-1:2 and MOB1A, and between hsa_circ_0001380 and hsa-miR-193b-3p suggest novel regulatory mechanisms in HCC progression. These findings provide new insights into the role of ncRNAs in HCC pathogenesis and identify potential avenues for future research and targeted therapies.
Zitieren
APA
Mirzaei-Nasab, F., Hashemi, M., Seyedena, Y., Hosseinkhan, N., & Majd, A. (2025). Integrative Analysis of Non-coding RNAs and Hippo Signaling Pathway in Hepatocellular Carcinoma Using Bioinformatics and Experimental Approaches. International Journal of Cancer Management, 18(1). https://doi.org/10.5812/ijcm-157228
Vancouver
Mirzaei-Nasab F, Hashemi M, Seyedena Y, Hosseinkhan N, Majd A. Integrative Analysis of Non-coding RNAs and Hippo Signaling Pathway in Hepatocellular Carcinoma Using Bioinformatics and Experimental Approaches. International Journal of Cancer Management. 2025;18(1). doi:10.5812/ijcm-157228
BibTeX
@article{MirzaeiNasab2025,
author = {Mirzaei-Nasab, Farzin and Hashemi, Mehrdad and Seyedena, Yousef and Hosseinkhan, Nazanin and Majd, Ahmad},
title = {Integrative Analysis of Non-coding RNAs and Hippo Signaling Pathway in Hepatocellular Carcinoma Using Bioinformatics and Experimental Approaches},
journal = {International Journal of Cancer Management},
year = {2025},
volume = {18},
number = {1},
doi = {10.5812/ijcm-157228}
}
EUVIMED